C-reactive protein makes human endothelium stiff and tight

Hypertension

Volumn 57, Issue 2, 2011, Pages 231-237

  Kusche Vihrog, Kristina ^a   Urbanova, Katarina ^a   Blanqué, Anja ^a   Wilhelmi, Marianne ^a   Schillers, Hermann ^a   Kliche, Katrin ^a   Pavenstädt, Hermann ^a   Brand, Eva ^a   Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

AFM; aldosterone; CRP; ENaC; immunofluorescence; NO; PI3K

Indexed keywords

ALDOSTERONE; C REACTIVE PROTEIN; EPITHELIAL SODIUM CHANNEL; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SPIRONOLACTONE;

ANIMAL CELL; ARTERIAL PRESSURE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOTHESIS; INCUBATION TIME; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RIGIDITY; SIGNAL TRANSDUCTION;

ALDOSTERONE; AMILORIDE; ANIMALS; AORTA; C-REACTIVE PROTEIN; CATTLE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EPITHELIAL SODIUM CHANNEL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICROSCOPY, ATOMIC FORCE; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; SODIUM AZIDE; VASODILATOR AGENTS;

EID: 79551486467     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.163444     Document Type: Article

References (52)

1. Virdis A, Ghiadoni L, Plantinga Y, Taddei S, Salvetti A. C-Reactive protein and hypertension: is there a causal relationship? Curr Pharm Des. 2007;13:1693-1698.
2. Savoia C, Schiffrin EL. Reduction of C-reactive protein and the use of anti-hypertensives. Vasc Health Risk Manag. 2007;3:975-983.
3. Fernandes D, Assreuy J. Nitric oxide and vascular reactivity in sepsis. Shock. 2008;30:10-13.
4. Kuhl SJ, Rosen H. Nitric oxide and septic shock. From bench to bedside. West J Med. 1998;168:176-181.
5. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439-1441.
6. Schneeweis C, Grafe M, Bungenstock A, Spencer-Hansch C, Fleck E, Goetze S. Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration. J Atheroscler Thromb. 2010;17:203-212.
7. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118-1122.
8. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, Yamashina A. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension. 2005;45:997-1003.
9. Funder JW. Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinol. 2006;147:5564-5567.
10. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.
11. Oberleithner H. Unorthodox sites and modes of aldosterone action. News Physiol Sci. 2004;19:51-54.
12. Rossier BC, Palmer LG. Mechanisms of aldosterone action on sodium and potassium transport. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. 21st ed. New York, NY: Raven Press; 1992:1373-1409.
13. Krug AW, Kopprasch S, Ziegler CG, Dippong S, Catar RA, Bornstein SR, Morawietz H, Gekle M. Aldosterone rapidly induces leukocyte adhesion to endothelial cells: a new link between aldosterone and arteriosclerosis? Hypertension. 2007;50:e156-e157.
14. Fiebeler A, Muller DN, Shagdarsuren E, Luft FC. Aldosterone, miner-alocorticoid receptors, and vascular inflammation. Curr Opin Nephrol Hypertens. 2007;16:134-142.
15. Gekle M, Grossmann C. Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch. 2009;458: 231-246.
16. Oberleithner H, Riethmuller C, Ludwig T, Hausberg M, Schillers H. Aldosterone remodels human endothelium. Acta Physiol (Oxf). 2006;187: 305-312.
17. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA. 2007;104: 16281-16286.
18. Fels J, Oberleithner H, Kusche-Vihrog K. Menage a trois: aldosterone, sodium and nitric oxide in vascular endothelium. Biochim Biophys Acta. 2010;1802:1193-1202.
19. Brown NJ. Aldosterone and vascular inflammation. Hypertension. 2008; 51:161-167.
20. Funder JW. Aldosterone, mineralocorticoid receptors and vascular inflammation. Mol Cell Endocrinol. 2004;217:263-269.
21. Jeong Y, Chaupin DF, Matsushita K, Yamakuchi M, Cameron SJ, Morrell CN, Lowenstein CJ. Aldosterone activates endothelial exocytosis. Proc Natl Acad Sci USA. 2009;106:3782-3787.
22. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102: 2165-2168.
23. Schwartz R, Osborne-Lawrence S, Hahner L, Gibson LL, Gormley AK, Vongpatanasin W, Zhu W, Word RA, Seetharam D, Black S, Samols D, Mineo C, Shaul PW. C-Reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res. 2007;100:1452-1459.
24. Oberleithner H, Callies C, Kusche-Vihrog K, Schillers H, Shahin V, Riethmuller C, MacGregor GA, de Wardener HE. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci USA. 2009;106:2829-2834.
25. Kusche-Vihrog K, Callies C, Fels J, Oberleithner H. The epithelial sodium channel (ENaC): mediator of the aldosterone response in the vascular endothelium? Steroids. 2009;75:544-549.
26. Hillebrand U, Schillers H, Riethmuller C, Stock C, Wilhelmi M, Oberleithner H, Hausberg M. Dose-dependent endothelial cell growth and stiffening by aldosterone: endothelial protection by eplerenone. J Hypertens. 2007;25:639-647.
27. Grinspan JB, Mueller SN, Levine EM. Bovine endothelial cells transformed in vitro by benzo (a) pyrene. J Cell Physiol. 1983;114:328-338.
28. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 1983;80:3734-3737.
29. Swafford AN Jr, Bratz IN, Knudson JD, Rogers PA, Timmerman JM, Tune JD, Dick GM. C-Reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations. Am J Physiol Heart Circ Physiol. 2005;288:H1786-H1795.
30. Carl P, Schillers H. Elasticity measurement of living cells with an atomic force microscope: data acquisition and processing. Pflugers Arch. 2008; 457:551-559.
31. Kusche-Vihrog K, Sobczak K, Bangel N, Wilhelmi M, Nechyporuk-Zloy V, Schwab A, Schillers H, Oberleithner H. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch. 2008;455: 849-857.
32. Riethmuller C, Jungmann P, Wegener J, Oberleithner H. Bradykinin shifts endothelial fluid passage from para- to transcellular routes. Pflugers Arch. 2006;453:157-165.
33. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91:1351-1357.
34. Oberleithner H, Ludwig T, Riethmuller C, Hillebrand U, Albermann L, Schafer C, Shahin V, Schillers H. Human endothelium: target for aldosterone. Hypertension. 2004;43:1-5.
35. Jungmann P, Wilhelmi M, Oberleithner H, Riethmuller C. Bradykinin does not induce gap formation between human endothelial cells. Pflugers Arch. 2008;455:1007-1016.
36. Oberleithner H. Is the vascular endothelium under the control of aldosterone? Facts and hypothesis. Pflugers Arch. 2007;454:187-193.
37. May A, Puoti A, Gaeggeler HP, Horisberger JD, Rossier BC. Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel a subunit in A6 renal cells. J Am Soc Nephrol. 1997;8:1813-1822.
38. Alvarez de la Rosa D, Li H, Canessa CM. Effects of aldosterone on biosynthesis, traffic, and functional expression of the epithelial sodium channel in A6 cells. J Gen Physiol. 2002;119:427-442.
39. McEneaney V, Harvey BJ, Thomas W. Aldosterone regulates rapid trafficking of epithelial sodium channel subunits in renal cortical collecting duct cells via protein kinase D activation. Mol Endocrinol. 2008;22: 881-892.
40. + channel surface expression. EMBO J. 2001;20:7052-7059.
41. + channel. J Biol Chem. 2002;277:5-8.
42. Cantiello HF, Stow JL, Prat AG, Ausiello DA. Actin filaments regulate epithelial Na channel activity. Am J Physiol. 1991;261:C882-C888.
43. Mazzochi C, Bubien JK, Smith PR, Benos DJ. The carboxyl terminus of the alpha-subunit of the amiloride-sensitive epithelial sodium channel binds to F-actin. J Biol Chem. 2006;281:6528-6538.
44. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280:1300-1306.
45. Perez FR, Venegas F, Gonzalez M, Andres S, Vallejos C, Riquelme G, Sierralta J, Michea L. Endothelial epithelial sodium channel inhibition activates endothelial nitric oxide synthase via phosphoinositide 3-ki-nase/Akt in small-diameter mesenteric arteries. Hypertension. 2009;53: 1000-1007.
46. Fels J, Callies C, Kusche-Vihrog K, Oberleithner H. Nitric oxide release follows endothelial nanomechanics and not vice versa. Pflugers Arch. 2010;460:915-923.
47. Rankin JA. Biological mediators of acute inflammation. AACN Clin Issues. 2004;15:3-17.
48. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA. 2005;102:904-908.
49. Di LA, Fernandez-Hernando C, Cirino G, Sessa WC. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci USA. 2009;106:14552-14557.
50. Oberleithner H, Riethmüller C, Ludwig T, Shahin V, Stock C, Schwab A, Hausberg M, Kusche K, Schillers H. Differential action of steroid hormones on human endothelium. J Cell Sci. 2006;119:1926-1932.
51. Abernathy VJ, Webster RO, Dahms TE. C-Reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. Am J Physiol. 1996;271:H507-H513.
52. Heuertz RM, Piquette CA, Webster RO. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol. 1993; 142:319-328.